Doing everything still losing hair
    Minoxidil 7/26/2025

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Finasteride (oral) 1 mg more than 4 years
    πŸ’Š Minoxidil (oral) 2.5 mg more than 4 years
    πŸ’Š Multivitamin (oral)
    πŸ’§ Finasteride-Minoxidil solution (topical) nightly
    the tone is 😞 negative with no growth results.

    Other terms

    The user is experiencing hair loss despite using 1 mg finasteride, 2.5 mg minoxidil, a multivitamin, and a topical finasteride-minoxidil solution. Suggestions include increasing minoxidil dosage, addressing vitamin deficiencies, especially Vitamin D, and considering lifestyle changes like diet and exercise.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results

      research Female pattern hair lossβ€”An update

      12 citations , January 2020 in “Indian Dermatology Online Journal”
      Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.
      Telogen Effluvium: Comprehensive Overview and Treatment

      research Telogen Effluvium

      3 citations , February 2008 in “Basic and clinical dermatology”
      Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.
      Low-Level Light Therapy and Hair Loss

      research Low-level light therapy and hair loss

      January 2012 in “Human health handbooks”
      Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.
      Hair Loss and Herbs for Treatment

      research Hair loss and herbs for treatment

      39 citations , September 2013 in “Journal of Cosmetic Dermatology”
      Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.
      Reporting on Adverse Clinical Events

      research Reporting on Adverse Clinical Events

      March 2021 in “Clin-Alert”
      The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.